SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001274644-15-000008
Filing Date
2015-03-11
Accepted
2015-03-11 16:04:34
Documents
3
Period of Report
2015-03-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ocera-form8xkearningsmarch.htm 8-K 26607
2 PRESS RELEASE DATED MARCH 11, 2015 exhibit991oceraearningsrel.htm EX-99.1 132066
3 oceralogo.jpg GRAPHIC 23227
  Complete submission text file 0001274644-15-000008.txt   192025
Mailing Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301
Business Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301 6504625800
Ocera Therapeutics, Inc. (Filer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35119 | Film No.: 15692585
SIC: 2834 Pharmaceutical Preparations